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We have recently described two types of muscarinic responses in native Xe~roprrs oocytes of different donors (common and variant) that display 
qualitative and quantitative differences (Lupu-Meiri et al., 1990). Here we characterized the muscarinic receptors mediating these two types. The 
anti-muscarinic toxins from Dentroaspis significantly inhibited responses in oocytes of common donors, but had little effect on responses in oocytes 
of variant donors. possibly indicating expression of different receptor subtypes. Using specific muscarinic antagonists, we found that oocytes of 
common donors exhibit a pattern compatible with the M3 subtype of muscarinic receptors. while oocytes of variant donors appear to possess 
receptors of the Ml subtype. To more directly determine the subtypes of muscarinic receptors in oocytes of both populations of donors. we have 
microinjected antisense oligonucleotides into native oocytes. Antisense oligonuclcotides to unique sequences in the N-terminal and the third cyto- 
plasmic loop of M3 muscarinic receptors caused a significant inhibition of the response of common oocytes, but had virtually no effect on responses 
in oocytes of variant donors. Conversely, oligonucleotides complementary to the unique sequences of the ml muscarinic receptors inhibited the 
response in variant oocytes, but not in oocytes of common donors. We conclude that native Xenopus oocytes of different donors phenotypically 
express either M3-like (majority) or Ml-like (minority) muscarinic receptor subtypes. The differences in receptor subtype expression may explain 
the different characteristics of responses in the two populations. 
Muscarinic receptor subtype; Xenopus oocyte; Antisense oligonucleotide 
1. INTRODUCTION 
Muscarinic membrane electrical responses in Xeno- 
yus Levis oocytes have been first described by Kusano 
et al. [I ] and characterized in detail by Dascal and Lan- 
dau It]. We have recently reported that oocytes of 
approximately 40% of all donors exhibit muscarinic 
responses. Of those, the majority (36%) conform to the 
characteristics described by Dascal and Landau [2], i.e. 
a rapid transient depolarizing current (Dl) followed by 
a slow, prolonged depolarizing current (D2) and super- 
imposed depolarizing current fluctuations (F). These 
responses have been denoted as ‘common’. Oocytes of 
approximately 4% of donors also exhibit a three-com- 
ponent depolarizing response. This response, though 
superficially similar to the ‘common’ response de- 
scribed above, is characterized by a much larger ampli- 
tude of the transient component, significantly larger 
*%a efflux, prolonged latency, lower sensitivity to col- 
lagenase treatment, profound desensitization, inhibi- 
tion clue to activation of protein kinase C and different 
magnitude of the response on the two hemispheres of 
the oocyte [3,4]. This response has been denoted as 
‘variant’. 
The qualitative and quantitative differences between 
the responses observed in ‘common’ and in ‘variant’ 
oocytes could be related to many factors, e.g. slightly 
different coupling of the signal transduction pathway. 
However, it is also possible that oocytes of the two 
types of donors express different subtypes of musca- 
rinic receptors. Van Wezenbeck et al. [5] have partially 
characterized the responses in oocytes of common 
donors as mediated by M3’receptor subtype. We, on the 
other hand, have observed that responses to ACh in 
oocytes injected with rat brain RNA (and coding pre- 
dominantly for Ml-receptor subtype) resemble respon- 
ses observed in oocytes of variant donors. Here, we 
characterize the sub-types of muscarinic receptors ex- 
pressed in both ‘common’ and ‘variant’ oocytes and 
conclude that while ‘common’ oocytes express mainly 
the M3-like, ‘variant’ oocytes express predominantly 
the Ml-like muscarinic receptor subtype. These find- 
ings may be important for the understanding of the ap- 
parent redundance of different muscarinic receptor 
subtypes. 
2, MATERIALS AND METHODS 
2, I , Ex~rcrittrctrtol atrittra/,s 
AcItrIc Xetto/trr.r fcmslcs, l,urcharcd from Sot~th Af’ricatr Xcnnltr~s 
I~ncility, wcrc nraintaitlcd aild fed as dcrcribcd [I). The animals WCIC 
cold~a~iacrthcai~cd and ovary fragntcilts H’CIC dislectcd into NDYlr 
mrdiuin. Stnpc 5 or 6 ao<vlr5 were ncparatctl and inaintni~rcd at 20°C 
Volume 284, number 2 FEBS LETTERS June 1991 
in NDE96. When the same donors were used repeatedly. dissections 
were spaced 2-3 weeks apart to allow a full recovery of the animals 
from the surgery. Where indicated, follicular cells were removed by 
collagenase as described [6]. 
2.2. Eleclropit.vsiology 
The electrophysiological methods were described in detail elsewhere 
[3,7]. Briefly, all experiments were performed under two-electrode 
voltage c!amp using Dagan 8500 intracellular clamp. Oocytes were 
routinely voltage-clamped at - 100 mV to minimize potassium cur- 
rent. Agonists were added rapidly and directly to the bath in > I ml 
of ND96 in order to avoid the dead time of the perfusion system and 
the gradual build-up of the drug’s concentration. 
2.3. Assay of Dendroaspis toxin adivity 
The antimuscarinic toxin fraction was a generous gift from 
Alomone Laboratories (Jerusalem) and was prepared as described by 
Adem et al. [S]. The final concentration of the toxin was 0.1 mg pro- 
tein/ml in ND96. Oocytes were pre-incubated in the toxin-containing 
solution for more than 45 min and then assayed for responses to IO 
PM ACh. Oocytes of ‘common’ and ‘variant’ donors were assayed at 
the same experiment intermittentIy. 
2.4. Assa_v of rnrtscarinic anragonists 
Five muscarinic antagonists were used. Atropine, pirenzepine, AF- 
DX 116, 5-diphenylacetoxy-N-methyl-piperidine methobromide 
(CDAMP) and himbacine. Follicle-enclosed oocytes of both types of 
donors were pre-incubated with different concentrations of the 
various antagonists for I S-20 min and then exposed simultaneously to 
10 PM ACh and the given concentration of the antagonist. Consider- 
ing the slow dissociation of the antagonists in follicle-enclosed 
oocytes (Davidson and Oron, unpublished), these measurements were 
equivalent to determining the fraction of receptors unoccupied by the 
antagonist. The results were always normalized to standard responses 
to IO PM ACh in the same experiment. 
2.5. Intracellular injections of oligonucleotides 
The oligonucleotides were synthesized on a 3808 Applied 
Biosystems DNA synthesizer and purified on a 20% acrylamide/l M 
urea preparative sequencing gel for each muscarinic ACh receptor 
mRNA sequence [9J, They were complementary to the nucleotide se- 
quence corresponding either to the amino terminus or to the third 
cytoplasmic loop. Oligomers were complementary to bases 189-225 
(anri ml/N), ll69-1210(anti ml/CL)of them1 receptor and to bases 
47-97 (anti m3/N), 1184-1231 (anti m3KL) of the m3 receptor. The 
specificity of the different oligonucleotidcs has been previously shown 
by Northern analysis in rat brain, where a hybridizing band could be 
dctectcd with both the appropriate size and brain region distribution 
and by in situ hybridization histochemistry [IO,1 I]. 
The oligonucleotidcs wcrc dissolved in distilled water and 0.5-10.0 
ng (38-675 fmol)/occyte were injected into single ooqcs (in 30-50 
nl/oocyte) using a VWR digital microdispcnser (10 111 maximal 
dclivcry) ..vith the capillary pulled to a 5-20 pm tip. Control oocytcs 
were sham injected with the same volume of distilled wntcr. Oocytcs 
wcrc assayed for rcsponrcs 2.5-S.0 h following their injection. 
2. G A f irtlysis (I./ rcsrilrs 
AlI cxpcrimcnts wcrc repeated several times in oocyrcs from dif- 
fcrcnt frogs. The number of oocylcs assayed for each condition is 
dcnotcd by lr and !hc number of donors by N’. Expcrimcnts wcrc pcr- 
formctl by assaying J-IO oocytcs within cnch cspcrimcnt and 
IllCilll 2 S.E,M. values wcrc dctcrinincd. Statistical niynificaticc was 
dctcrmined by S~udcnr’s /-tcsl. 
Ttic coniposltinn nf ND96 was (in nihl): NaCl 96, KCI 2, h1gCI: I, 
C’aCI: 1.8, Na.Hcpcs S. pi-i 7.5. NDE96 included additionnlly Na. 
pyruvalc (2.5 nr>l). ACti, iitropinc, pircnxenlnc and cnll;rgcnn%e (type 
IA) were l*urch%cd irnnr Sigma. AF-13X I16 wiw 3 gift of i)r. Karl 
‘rllonl;lc. OltW4( Uibcrach, Gcr~mny), J.DAhlP wa$ a girl of Dr. 
R.B. Barlow (University of Bristol), himbacine hydrochloride was a 
gift of Dr. WK. Taylor (University of Sidney). All other chemicals 
were of analytical grade. 
3. RESULTS 
3.1. The effect of anti-muscarinic toxins from 
Dendroaspis 
Muscarinic responses in oocytes of common and 
variant donors exhibit multiple differences [3]. Typical 
responses are shown in Fig. I&B. To obtain prelimi- 
nary evidence that these two types of responses result 
A C 
I 
s 
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P 
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Fig. I. I~eprrrcntotlvr rcspotlrcs of ~IWIOII (A) and variant (B) 
oocytcs IO IO/c>1 AC_%. The holding potenlial was - IOnrV. No~c the 
diffcrcnt calibration. !?milar responses nftcr 65-75 min incubation 
with 0.1 1iip9id Dcnoioarpir loxinr arc shown ror coninio~ (C) and 
varianl (0) oocytcr. The slnu- ~ninponent of lhs rrspnnsc was not 
recorded la variant oocy~cr. 
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Fig. 2. Dose-response curves for the inhibition of the rapid compo- 
nent (DI) of the responses to IO ,rM ACh by pirenzepine (A) or AF- 
DX-I 16 (B). Each point represents the mean of 18-30 determinations 
in individual oocytes from 3-5 different donors. In each experiment, 
values were normalized as percent of the control response to IO PM 
ACh (100%). C, common, V, variant oocytes. 
from the activation of two different receptor subtypes, 
we base used anti-muscarinic toxins from the green 
mamba snake (Dendroaspis angusticeps). It has been 
reported that these toxins compete for approximately 
50% of specific muscarinic ligand binding in brain 
homogenates [8]. This implies that the toxins recognize 
some, but not all muscarinic receptor subtypes and may 
be used as tools for receptor discrimination. 
Indeed, incubation of oocytes of common donors 
with 0.1 mg/ml of the toxins solution resulted in signifi- 
cant (48-~6%) inhibition of the Di component of the 
response (n = 53, N= 4). The same batches of toxins 
had little effect on the rapid component of the response 
in oocytes of variant frogs (1C t 3’70 inhibition, n = 32, 
N= 3). Representative responses are shown in Fig. 
lC,D. These results implied that oocytes of common 
and variant donors express different receptor subtypes. 
3.2. The effect of muscarinic antagonists 
The order of potency of muscarinic antagonists was 
similar in inhibiting the muscarinic responses in oocytes 
of both common and variant donors. In both cases, the 
order of potency was: atropine > DAMP > pirenze- 
pine > AF-DX 116 (see Fig. 2 for representative curves 
of pirenzepine and AF-DX-116 inhibition). The MZ-se- 
lective antagonist, himbacine, exhibited very low poten- 
cy against responses in oocytes of both ‘common’ and 
‘variant’ donors. The I&O values for the various an- 
tagonists in common. and variant oocytes were very 
close to those reported in radioligand binding studies in 
salivary gland (M3) and brain (Ml), respectively [12] 
(see Table I). Hence, judging by the order of potency 
and similarities to receptor binding data in represen- 
tative tissues, common oocytes appear to express main- 
ly ivi3-like, while variant oocytes exhibit Ml-like 
muscarinic receptor subtypes. 
3.3. The effect of complentary oligonucfeotide 
probes 
Although the results obtained with the muscarinic an- 
tagonists are suggestive, they do not make a definite 
proof. This is due to the poor selectivity of the an- 
tagonists, the rapid and transient nature of the response 
(which precludes the use of competitive pharmacologi- 
cal analysis (e.g. Schild plots)) and the relatively low 
signal-to-noise ratio in radioligand binding experiments 
[3]. More importantly, the pharmacological tools are 
very poor in discriminating between the recently cloned 
m4 abtypes [ 131, 
For all the reasons described above, we have decided 
Table I 
- lop(lC~n) values of muscarinic antagonists 
Antagonist Common Snlivilry gland* Vilriilllt l?.r;tin* 
Dl D2 II1 D2 - 
Atrophic 8.Y 8.Y (8.9) 9.0 8.8 (9.2) 
4-DAMP 800 7.2 (8.5) 8.S 6.8 (8.7) 
Pircnzcpinc 6.-t A.5 (6.4) 7.3 (1.5 (7.41 
AF-D&I 16 5.4 5.2 (5.3) 6.7 4.u (6.1) 
Hinlbacinc .t,O 4-7 - 5.5 >5.0 - 
Dose-rcsponsc curves \vcrc grncratcd to the various antnponisls as dcrsribcd in Fig . 2 for the rapid ~onipotrcnt 
of lhc responses IDI). Data role Ihc slow ~o~ii~~c~~ic~ii of tlic rcqxni*e~ (D?) vvcrc oblniircd In an identicnl mitttncr, 
*The values iii piirciithcses rrt,rr~cnt - l@,g K, for (‘HJ.;~-~iiclhy~r~o~rntut~iiiic binding iakcii from Dond~ 
Cl ;11, 1121. 
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Fig. 3. The effect of anti-ml or anti-m3 oligonucleotides. The bars 
represent he means? SE of 9 individual experiments in common and 
variant oocytes, injected with 0.5 to 10.0 ng of the anti-ml or anti-m3 
oligonucleotides. Each value represents assay results of 25-68 oocytes 
from 4-6 different donors. 
to conclusively identify the oocyte receptor subtypes by 
synthesizing antisense oligonucleotides complementary 
to unique sequences at the N-terminal and the third 
cytoplasmic loop regions of the ml and m3 receptors. 
Injection of a large excess of a suitable oligonucleotide 
should result in the formation of DNA-mRNA hybrids 
in vivo. These double-stranded hybrids are rapidly 
degraded by RNase H, resulting in a loss of specific 
mRNA activity [14,15]. Provided that the turnover of 
membrane receptors is rapid, injection of a suitable 
probe would result in a rapid decrease in its activity. 
Indeed, injection of antisense oligonucleotides for 
the m3 receptor, significantly (PcO.01) inhibited the 
response to ACh in oocytes of common donors (by 
41 -I- 70/o), but had little effect on the response in oocytes 
of variant donors. Conversely, oligonucleotides for the 
ml receptor inhibited by 55 + 11% (P<O.Ol) the 
response in oocytes of variant donors, but had negligi- 
ble effect on the response in oocytes of common 
donors. These results are shown in Fig. 3. 
4. DISCUSSION 
Xctmprrs oocytes exhibit two types of intrinsic 
muscarinic responses [3]. Both types appear to utilize 
the G-protein-PlPz-IPJ-calcium cascade and both con- 
sist of a multicomponent increase in chloride conduc- 
tance. The many quantitative and qualitative differen- 
ces in their characteristics cannot be ascribed to the 
large discrepancy in amplitude alone, since the mag- 
nitudes of the responses in oocytes of the two popula- 
tions of donors sometimes overlap considerably. Like- 
wise, the number of muscarinic rcccptors appears to bc 
similar in oocytes of both types of donors [3]. WC have 
iuvcstigatcd the possibility that native oocytes may cx- 
press two subtypes of muscarinic receptors that couple 
to the same signal transduction pathway. 
The pharmecologicol cvidcnrc strongly suygcsts that 
indeed common and variant clonors express different 
types of muscarinic receptors. To briefly summarize the 
evidence, the two populations appear to be affected dif- 
ferently by the muscarinic toxins of the Dendroaspis 
venom and the EC50 values to a series of muscarinic 
antagonists imply the predominance of M3 subtype in 
common and of Ml subtype in variant oocytes, respec- 
tively. 
Because of the relative shortcomings of classical 
pharmacological tools in this system, we have validated 
these findings by selectively inhibiting the synthesis of 
Ml and M3 receptors in vivo, using specific antisense 
oligonucleotides directed against non-homologous 
regions of cloned ml and m3 receptors. These experi- 
ments conclusively demonstrated that the muscarinic 
responses in common oocytes are mainly mediated by 
the stimulation of M3-like receptors, while those of the 
variant oocytes are due to Ml-like receptors. We cannot 
exclude the possibility that oocytes express receptors 
that are slightly different from but highly homologous 
to the cloned ml and m3 subtypes, at least in the regions 
probed by the oligonucleotide sequences. The success of 
identifying a gene product in an intact cell by injection 
of antisense oligonucleotides opens a new pharmaco- 
logic tool for distinguishing among polymorphous 
species that may be expressed in large cells and that ex- 
hibits a relatively rapid turnover. 
Several groups have demonstrated that both ml and 
m3 receptor subtypes couple to the PIPz-IP3-calcium 
cascade [ 16-181. This evidence is particularly convinc- 
ing when both subtypes are transiently overexpressed in 
CHO-Kl cells [19]. We should ask, therefore, why two 
receptors that couple to the same signal transduction 
pathway in the same cell exhibit multiple qualitative 
and quantitative differences in their responses’ charac- 
teristics (31 and hemispheric distribution [4]. One 
possibility is interaction with different populations of 
G-proteins. This possibility is supported by the reports 
of Kubo et al. [20] and Bujo et al. [21]. Overexpression 
of m3 receptors in Xenopus oocytes resulted in mem- 
brane electrical responses that wcrc identical to those 
obtained by overexpression of ml receptors. Similarly, 
m2 and m4 receptors, usually involved in the inhibition 
of the adenylate cyclase and in G-protein-mediated ac- 
tivation of ionic channels, when overexpressed in model 
systems may couple to the PlPz-IPJ-calcium cascade. 
Thcsc findings have been ascribed to the promiscuity of 
the G-proteins, especially at high receptor lcvcls [13]. 
The differences between the responses to the activa- 
tion of the two types of receptors in native oocytes may 
rcprcscnt the true specificity of the various subtypes of 
muscarinic receptors and a search for the native G- 
proteins participating in these responses may yield im- 
portant information. The differential coupling to 
various G-proteins may bc also a function of the 
topography of their expression. WC have demonstrated 
that native Ml receptors show mnrkcd prcferencc for 
the alrimal hcmisphcrc of the oocytc, while M3 recep- 
255 
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tors appear to be distributed evenly over the surface of 
the cell [4]. The reason for these differences in receptor 
sorting may be related to the primary structure of the 
two peptides and future studies of their non- 
homologous regions should be potentially rewarding. 
Acknowledgements: This work was supported by grants from the US- 
Israel Bi-National Science Foundation and of the Basic Research 
Foundation of the Israel Academy of Sciences and Humanities. 
This work was done to partially fulfil the Ph.D. thesis requirements 
of N.M.-L. 
REFERENCES 
111 
[21 
131 
[41 
PI 
[61 
[‘I 
181 
Kusano, K., Miledi. R. and Stinnakre, J. (1977) Nature 270, 
739-741, 
Dascal. N. and Landau, E.M. (1980) Life Sci. 27, 1423-1428. 
Lupu-Meiri, M., Shapira, H., Matus-Leibovitch. N. (1990) 
Pfliigers Arch. 417, 391-397. 
Matus-Leibovitch. N.. Lupu-Meiri. M. and Oron, Y. (1990) 
Pfliigers Arch. 417, 194-199. 
Van Wezenbeek, L.A.C.M., Tonnaer, J.A.D.M. and Ruigt, 
G.S.F. (1988) Eur. J. Pharmacol. 151, 497-500. 
Dascal, N.. Landau, E.M. and Lass, Y. (1984) J. Physiol. 352, 
55 1-574. 
Lupu-Meiri, M., Shapira, H. and Oron, Y. (1989) Pflugers 
Arch. 413, 498-504. 
Adem, A., Asblom, A., Johansson, G., Mbugua, P.M. and 
Karlsson, E. (1988) Biochim. Biophys. Acta 968. 340-345. 
PI 
t101 
[Ill 
1121 
I131 
1141 
[ISI 
1161 
iI71 
[I81 
1191 
WI 
I2ll 
Bonner, T.I., Buckley, N.J., Young, A.C. and Brann, M.R. 
(1987) Science 237, 527-532. 
Vilaro. M.T., Martinez-Mir, M.I., Sarasa. M., Pomopeiano, 
M.. Palacios. J.M. and IMengod, G. (1990) in: Current Aspects 
of the Neurosciences (N.N. Osborne, ed.) vol. 3, pp. l-35. Mac- 
Millan. 
Vilaro, ;M.T., Wiederhold. K.H.. Palacios. J&l. and Mengod, 
G. (1990) Neuroscience, in press. 
Doods, H.N., Mathy, M.-J., Davidesko, D., Van Charldorp, 
K.J.. De Jonge, A. and Van Zwieten. P.A. (1987) J. Pharmacol. 
Exp. Ther. 242, 257-262. 
Banner, T.I. (1989a) Trends Pharmacol. Sci., Subtypes of 
muscarinic receptors IV (Suppl.) I I-15. 
Shuttleworth, .I. and Colman, A. (1988) EMBO J. 7, 427-434. 
Dash, P., Lotan, I., Knapp, M., Kandell, E.R. and Goelet, P. 
(1987) Proc. Natl. Acad. Sci. USA 84. 7896-7900. 
Ashkenazi, A., Winslow, J.W., Peralta, E.G., Peterson, G.L., 
Schimerlick, M.I., Capon, D.J. and Ramachandran, J. (1987) 
Science 238, 672-675. 
Bonner, T.I. (1989) Trends Neurosci. 12, 148-151. 
Fukuda, K., Kubo, T., Maeda, A.. Akiba, I., Bujo. H.. Nakai, 
J., Mishina, M., Higashida, H., Neher, E., Marty, A. and 
Numa, S. (1989) Trends Pharmacol. Sci., Subtypes of 
muscarinic receptors IV (Suppl.), 4-10. 
Buckley, N.J., Bonner, T.I., Buckley, C.M. and Brann, R. 
(1989) Mol. Pharmacol. 35, 469-476. 
Fukuda, K., Kubo, T., Akiba. I.. Maeda. A., Mishina, M. and 
Numa, S. (1987) Nature 327, 623-625. 
Bujo, H., Nakai. J., Kubo, T., Fukuda, K., Akiba, I., Maeda, 
A., Mishina, M. and Numa, S. (1988) FEBS Lett. 240, 95-100. 
256 
